Myriad Genetics | MYGN - Stock


Myriad Genetics reported $30.6M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Agilent USD 1.06B 34M Dec/2025
Becton, Dickinson and Co. USD 4.08B 191M Dec/2025
Bio-Rad Laboratories USD 740.7M 42.5M Dec/2025
Bruker USD 1.2B 21.7M Sep/2025
Danaher USD 2.49B 185M Dec/2025
Hologic USD 688.5M 9.1M Dec/2025
Illumina USD 564M 26M Dec/2025
J&J USD 14.19B 45M Dec/2025
Mettler Toledo International USD 387.23M 14.58M Dec/2025
Myriad Genetics USD 30.6M 1000K Dec/2025
OraSure Technologies USD 31.06M 2.34M Dec/2025
Pacific Biosciences Of California USD 49.28M 3.87M Dec/2025
Quest Diagnostics USD 189M 3M Dec/2025
Quidel USD 577.6M 36.2M Dec/2025
Repligen USD 170.46M 10.14M Dec/2025
Revvity USD 379.5M 420K Dec/2025
Standard Biotools USD 19.98M 5.44M Dec/2025
Thermo Fisher Scientific USD 5.43B 320M Dec/2025
Veracyte USD 20.55M 219K Dec/2025
Waters USD 572.37M 570K Dec/2025